Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
Releases - December 05, 2016

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission after more than two years
Hutch News - December 05, 2016

‘Can’t sit and wait’: Gene therapy trial aims to cure rare Fanconi anemia

At annual hematology meeting, Fred Hutch researchers updated their treatment of 11-year-old Behzad
Hutch News - December 04, 2016

CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL

Results of early-phase trial of patients with chronic lymphocytic leukemia will be presented by Fred Hutch researchers at the American Society of Hematology Annual Meeting and Exposition
Releases - December 03, 2016

Fred Hutch research to be presented at American Society of Hematology conference

Fred Hutch researchers to share latest research in immunotherapy, genetic markers, graft vs. host disease, cord blood and more
Releases - November 29, 2016
Last Modified, August 15, 2019